Tomomi Kogiso

1.6k total citations · 1 hit paper
74 papers, 1.0k citations indexed

About

Tomomi Kogiso is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Tomomi Kogiso has authored 74 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Epidemiology, 41 papers in Hepatology and 22 papers in Surgery. Recurrent topics in Tomomi Kogiso's work include Liver Disease Diagnosis and Treatment (40 papers), Liver Disease and Transplantation (22 papers) and Diet, Metabolism, and Disease (19 papers). Tomomi Kogiso is often cited by papers focused on Liver Disease Diagnosis and Treatment (40 papers), Liver Disease and Transplantation (22 papers) and Diet, Metabolism, and Disease (19 papers). Tomomi Kogiso collaborates with scholars based in Japan, Canada and Ukraine. Tomomi Kogiso's co-authors include Katsutoshi Tokushige, Makiko Taniai, Etsuko Hashimoto, Kazuhisa Kodama, Keiko Shiratori, Hikaru Nagahara, Motoyuki Otsuka, Masakazu Yamamoto, Kazuhiko Koike and Nobuyuki Torii and has published in prestigious journals such as Gastroenterology, PLoS ONE and Scientific Reports.

In The Last Decade

Tomomi Kogiso

67 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020

2021 179 citations Katsutoshi Tokushige, Motoyuki Otsuka et al. profile →

Peers

Countries citing papers authored by Tomomi Kogiso

Since Specialization

Citations

This map shows the geographic impact of Tomomi Kogiso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomomi Kogiso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomomi Kogiso more than expected).

Fields of papers citing papers by Tomomi Kogiso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomomi Kogiso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomomi Kogiso. The network helps show where Tomomi Kogiso may publish in the future.

Co-authorship network of co-authors of Tomomi Kogiso

This figure shows the co-authorship network connecting the top 25 collaborators of Tomomi Kogiso. A scholar is included among the top collaborators of Tomomi Kogiso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomomi Kogiso. Tomomi Kogiso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prediction of hepatocellular carcinoma in patients with Fontan‐associated liver disease using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid magnetic resonance imaging 2024 ·Hepatology Research ·Atsushi Yamamoto, Michinobu Nagao, (unknown), (unknown), (unknown), (unknown), Satoru Morita, (unknown), Tomomi Kogiso, Koichiro Kaneko, Katsutoshi Tokushige, Kei Inai, (unknown), Junichi Yamaguchi	2
2	Epidemiology of Fontan‐associated liver disease in Japan: Results from a nationwide survey in 2021 2024 ·Hepatology Research ·Satoko Ohfuji, Atsushi Tanaka, Tomomi Kogiso, Tatsuya Kanto	3
3	Evaluation of diagnostic criteria for mild‐to‐advanced stages of Fontan‐associated liver disease: A nationwide epidemiological survey in Japan 2024 ·Hepatology Research ·Tomomi Kogiso, Daisuke Tokuhara, Satoko Ohfuji, Atsushi Tanaka, Tatsuya Kanto	0
4	Analysis of genetic factors associated with fatty liver disease‐related hepatocellular carcinoma 2023 ·Cancer Medicine ·Tomomi Kogiso, (unknown), Kentaro Horiuchi, Makiko Taniai, Katsutoshi Tokushige	8
5	A case of neuroendocrine carcinoma with massive invasion to the liver and multiorgan causing acute liver failure 2023 ·Clinical Journal of Gastroenterology ·(unknown), Naoko Ito, Tomomi Kogiso, (unknown), Yoji Nagashima, Katsutoshi Tokushige	1
6	Cell‐free and concentrated ascites reinfusion therapy versus large‐volume paracentesis for the treatment of cirrhotic patients with refractory ascites: A multicenter prospective observational study 2022 ·Hepatology Research ·Tatsunori Hanai, Hideto Kawaratani, Junji Nagano, (unknown), Akira Sakamaki, Yoshitaka Arase, Hiroyuki Nakanishi, Tomomi Kogiso, Tomomi Okubo, Takao Miwa, Shogo Shimizu, Shuhei Hige, Masanori Atsukawa, Masahito Shimizu, Masayuki Kurosaki, Shuji Terai, Tatehiro Kagawa, Katsutoshi Tokushige, Hitoshi Yoshiji	2
7	The utility of liver transplantation to treat acute liver failure caused by adult-onset Still’s disease: case reports 2021 ·Clinical Journal of Gastroenterology ·(unknown), Tomomi Kogiso, Yoshihito Kotera, Akiko Omori, (unknown), (unknown), (unknown), Makiko Taniai, Masayoshi Harigai, Hiroto Egawa, Masakazu Yamamoto, Katsutoshi Tokushige	3
8	Current Status of Portopulmonary Hypertension andHepatopulmonary Syndrome 2020 ·Kazuhisa Kodama, (unknown), Etsuko Hashimoto, Tomomi Kogiso, (unknown), (unknown), Katsutoshi Tokushige, Nobuhisa Hagiwara	2
9	Outcomes of Japanese patients with non-alcoholic fatty liver disease according to genetic background and lifestyle-related diseases 2020 ·Annals of Hepatology ·Tomomi Kogiso, (unknown), Kazuhisa Kodama, Makiko Taniai, Etsuko Hashimoto, Katsutoshi Tokushige	6
10	Fontan-associated liver disease and hepatocellular carcinoma in adults 2020 ·Scientific Reports ·Tomomi Kogiso, Katsutoshi Tokushige	25
11	The characteristics and risk factors of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis 2019 ·Journal of Gastroenterology and Hepatology ·Maki Tobari, Etsuko Hashimoto, Makiko Taniai, Kazuhisa Kodama, Tomomi Kogiso, Katsutoshi Tokushige, Masakazu Yamamoto, (unknown), Satoshi Katagiri, Tatsuo Araida	42
12	Hepatocellular carcinoma after direct‐acting antiviral drug treatment in patients with hepatitis C virus 2018 ·JGH Open ·Tomomi Kogiso, (unknown), Kazuhisa Kodama, Makiko Taniai, Satoshi Katagiri, Hiroto Egawa, Masakazu Yamamoto, Katsutoshi Tokushige	12
13	Differences in the genetic backgrounds of patients with alcoholic liver disease and non‐alcoholic fatty liver disease 2018 ·JGH Open ·(unknown), Tomomi Kogiso, Makiko Taniai, Etsuko Hashimoto, Katsutoshi Tokushige	15
14	Mycophenolate mofetil may induce prolonged severe anemia during pegylated-interferon/ribavirin/simeprevir therapy in liver transplant recipients 2015 ·Clinical Journal of Gastroenterology ·Tomomi Kogiso, Katsutoshi Tokushige, Etsuko Hashimoto, Makiko Taniai, Akiko Omori, Yoshihito Kotera, Hiroto Egawa, Masakazu Yamamoto, Keiko Shiratori	6
15	Spontaneous clearance of HCV accompanying hepatitis after liver transplantation 2015 ·Clinical Journal of Gastroenterology ·Tomomi Kogiso, Etsuko Hashimoto, (unknown), Kazuhisa Kodama, Makiko Taniai, Nobuyuki Torii, Hiroto Egawa, Masakazu Yamamoto, Katsutoshi Tokushige	5
16	Characteristics of gender differences and age in nonalcoholic steatohepatitis with regard to the complications of lifestyle-related disease, fat distribution, adipocytokines and SNPs 2014 ·Kanzo ·Tomomi Kogiso, Etsuko Hashimoto, Katsutoshi Tokushige, (unknown), Kazuhisa Kodama, Maki Tobari, Noriko Matsushita, Makiko Taniai, Nobuyuki Torii, Keiko Shiratori	4
17	Efficient Induction of Apoptosis by Wee1 Kinase Inhibition in Hepatocellular Carcinoma Cells 2014 ·PLoS ONE ·Tomomi Kogiso, Hikaru Nagahara, Etsuko Hashimoto, Shun‐ichi Ariizumi, Masakazu Yamamoto, Keiko Shiratori	24
18	Transdifferentiation of human fibroblasts into hepatocyte-like cells by defined transcriptional factors 2013 ·Hepatology International ·Tomomi Kogiso, Hikaru Nagahara, Motoyuki Otsuka, Keiko Shiratori, Steven F. Dowdy	22
19	Roles of gender, obesity, and lifestyle‐related diseases in alcoholic liver disease: Obesity does not influence the severity of alcoholic liver disease 2011 ·Hepatology Research ·Makiko Taniai, Etsuko Hashimoto, Katsutoshi Tokushige, Kazuhisa Kodama, Tomomi Kogiso, Nobuyuki Torii, Keiko Shiratori	14
20	Clinical significance of fatty liver associated with metabolic syndrome 2007 ·Hepatology Research ·Tomomi Kogiso, (unknown), Hikaru Nagahara	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact